Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction.

Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction. Pharm Res. 2012 Dec; 29(12):3455-63.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.